Cargando…
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Autor principal: | Lafyatis, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007732/ http://dx.doi.org/10.1186/1479-5876-8-S1-I14 |
Ejemplares similares
-
Biological ageing is a key determinant in systemic sclerosis
por: Shiels, Paul G, et al.
Publicado: (2011) -
A genomic approach to biomarker discovery in human autoimmune diseases
por: Pascual, V
Publicado: (2010) -
Therapeutic inhibition of proteasomes in systemic lupus erythematosus
por: Hiepe, Falk, et al.
Publicado: (2011) -
Central nervous system effects of tumor necrosis factor alpha blockade
por: Schett, Georg
Publicado: (2011) -
Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients
por: Aarntzen, EHJG, et al.
Publicado: (2010)